PROPOFOL

PROPOFOL was reported 37019 times

PROPOFOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROPOFOL INFUSION SYNDROME 626 0.8879
1 TRIGEMINO-CARDIAC REFLEX 58 0.7160
2 ANTI FACTOR V ANTIBODY 20 0.7143
3 NEGATIVE PRESSURE PULMONARY OEDEMA 67 0.6837
4 MITOCHONDRIAL DNA MUTATION 38 0.4419
5 NEUROMUSCULAR BLOCK PROLONGED 143 0.3875
6 NEW ONSET REFRACTORY STATUS EPILEPTICUS 39 0.3545
7 DELAYED RECOVERY FROM ANAESTHESIA 326 0.3439
8 AIRWAY PEAK PRESSURE INCREASED 51 0.3355
9 AIRWAY COMPLICATION OF ANAESTHESIA 88 0.3346
10 PSEUDOCHOLINESTERASE DEFICIENCY 21 0.3231
11 POSTOPERATIVE DELIRIUM 60 0.3030
12 MYOGLOBIN URINE PRESENT 72 0.2927
13 ANAESTHETIC COMPLICATION PULMONARY 26 0.2921
14 HYPERTHERMIA MALIGNANT 416 0.2794
15 MECHANICAL VENTILATION COMPLICATION 41 0.2752
16 TRACHEAL DEVIATION 24 0.2727
17 ALLERGY TEST NEGATIVE 40 0.2564
18 UNWANTED AWARENESS DURING ANAESTHESIA 82 0.2500
19 RECURRENCE OF NEUROMUSCULAR BLOCKADE 42 0.2456
20 BURKHOLDERIA TEST POSITIVE 28 0.2258
21 ANAESTHETIC COMPLICATION NEUROLOGICAL 203 0.2241
22 NEUROMUSCULAR BLOCKADE 46 0.2054
23 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 78 0.2053
24 INTRA-ABDOMINAL PRESSURE INCREASED 32 0.2038
25 CSF OLIGOCLONAL BAND PRESENT 25 0.1923
26 CONFUSION POSTOPERATIVE 24 0.1832
27 PROCEDURAL HYPOTENSION 140 0.1645
28 MYOCARDIAL DEPRESSION 37 0.1434
29 PHRENIC NERVE PARALYSIS 30 0.1370
30 PHAEOCHROMOCYTOMA CRISIS 27 0.1274
31 NECROSIS ISCHAEMIC 56 0.1215
32 ANAPHYLACTOID SHOCK 56 0.1191
33 HEPATIC ISCHAEMIA 36 0.1158
34 CARCINOID CRISIS 24 0.1062
35 TRYPTASE INCREASED 71 0.0994
36 SPINAL MUSCULAR ATROPHY 26 0.0963
37 INSPIRATORY CAPACITY DECREASED 26 0.0939
38 POSTOPERATIVE FEVER 25 0.0893
39 ANAPHYLACTIC SHOCK 2182 0.0845
40 ANAESTHETIC COMPLICATION 221 0.0822
41 PCO2 INCREASED 58 0.0815
42 MATERNAL EXPOSURE DURING DELIVERY 80 0.0807
43 TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 68 0.0802
44 DIABETES INSIPIDUS 189 0.0784
45 RENAL ISCHAEMIA 40 0.0731
46 PO2 INCREASED 37 0.0730
47 ENDOTRACHEAL INTUBATION COMPLICATION 41 0.0695
48 BLOOD GASES ABNORMAL 37 0.0686
49 PRODUCT CONTAMINATION MICROBIAL 81 0.0679
50 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 24 0.0661
51 PNEUMATOSIS 29 0.0652
52 HYPOCAPNIA 27 0.0646
53 OPISTHOTONUS 51 0.0641
54 NEONATAL RESPIRATORY DEPRESSION 21 0.0633
55 SKIN TEST POSITIVE 59 0.0632
56 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 22 0.0632
57 LARYNGOSPASM 167 0.0620
58 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 205 0.0618
59 VASOPLEGIA SYNDROME 99 0.0603
60 ELECTROMECHANICAL DISSOCIATION 48 0.0601
61 PROCEDURAL VOMITING 39 0.0600
62 LABILE BLOOD PRESSURE 71 0.0598
63 RESPIRATORY ACIDOSIS 235 0.0597
64 BRONCHOSPASM 833 0.0583
65 DRUG EFFECT PROLONGED 32 0.0580
66 MULTIPLE-DRUG RESISTANCE 176 0.0567
67 MYOGLOBINURIA 30 0.0563
68 OPERATIVE HAEMORRHAGE 25 0.0559
69 ACIDOSIS HYPERCHLORAEMIC 33 0.0556
70 UPPER AIRWAY OBSTRUCTION 49 0.0552
71 PULSELESS ELECTRICAL ACTIVITY 229 0.0547
72 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 58 0.0546
73 BRADYCARDIA FOETAL 44 0.0529
74 CONGESTIVE HEPATOPATHY 23 0.0513
75 ISCHAEMIC CEREBRAL INFARCTION 59 0.0508
76 BRUGADA SYNDROME 52 0.0502
77 RESPIRATORY TRACT INFECTION BACTERIAL 25 0.0502
78 STRESS CARDIOMYOPATHY 287 0.0493
79 MACROGLOSSIA 27 0.0492
80 NON-CARDIOGENIC PULMONARY OEDEMA 52 0.0491
81 STATUS EPILEPTICUS 548 0.0485
82 PROCEDURAL NAUSEA 39 0.0484
83 KOUNIS SYNDROME 109 0.0480
84 HAEMODYNAMIC INSTABILITY 362 0.0475
85 HYPERCAPNIA 142 0.0471
86 HEPATORENAL FAILURE 28 0.0465
87 LOCKED-IN SYNDROME 21 0.0456
88 HYPOVENTILATION 148 0.0454
89 ANTICHOLINERGIC SYNDROME 71 0.0445
90 PNEUMOCOCCAL SEPSIS 29 0.0441
91 PLEOCYTOSIS 25 0.0430
92 DRUG LEVEL CHANGED 27 0.0429
93 VOCAL CORD DYSFUNCTION 21 0.0426
94 AIR EMBOLISM 20 0.0425
95 ABDOMINAL COMPARTMENT SYNDROME 27 0.0424
96 CLONUS 114 0.0416
97 SINUS ARREST 64 0.0408
98 SEIZURE LIKE PHENOMENA 68 0.0400
99 FOETAL EXPOSURE DURING DELIVERY 27 0.0398
100 LARYNGEAL STENOSIS 23 0.0398
101 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 43 0.0391
102 APNOEIC ATTACK 22 0.0390
103 SEROTONIN SYNDROME 742 0.0386
104 RESUSCITATION 64 0.0386
105 CARDIAC OUTPUT DECREASED 34 0.0385
106 ARTERIOSPASM CORONARY 152 0.0378
107 SUBCUTANEOUS EMPHYSEMA 37 0.0377
108 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 82 0.0373
109 NEPHROGENIC DIABETES INSIPIDUS 42 0.0364
110 STRIDOR 105 0.0357
111 RESPIRATORY DEPRESSION 437 0.0356
112 SUSPECTED PRODUCT CONTAMINATION 36 0.0355
113 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 92 0.0351
114 VENTRICULAR FIBRILLATION 379 0.0341
115 TONIC CLONIC MOVEMENTS 44 0.0338
116 BLOOD PH DECREASED 57 0.0333
117 INTESTINAL PSEUDO-OBSTRUCTION 29 0.0330
118 ANAPHYLACTIC REACTION 1762 0.0319
119 SEDATION COMPLICATION 81 0.0317
120 CLONIC CONVULSION 23 0.0314
121 CIRCULATORY COLLAPSE 529 0.0310
122 INTESTINAL ISCHAEMIA 171 0.0310
123 HYPERTRIGLYCERIDAEMIA 181 0.0309
124 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 25 0.0304
125 MYOCLONIC EPILEPSY 46 0.0303
126 APNOEA 236 0.0303
127 BLOOD PRESSURE IMMEASURABLE 46 0.0300
128 TYPE I HYPERSENSITIVITY 105 0.0298
129 ELECTROENCEPHALOGRAM ABNORMAL 93 0.0294
130 PCO2 DECREASED 28 0.0290
131 APGAR SCORE LOW 37 0.0287
132 BRADYARRHYTHMIA 46 0.0280
133 HEPATORENAL SYNDROME 47 0.0278
134 ENDOTRACHEAL INTUBATION 76 0.0271
135 MYOCLONUS 323 0.0271
136 TORSADE DE POINTES 210 0.0267
137 PERFORATION 21 0.0261
138 PULSE ABSENT 124 0.0260
139 ANAPHYLACTOID REACTION 107 0.0260
140 NODAL RHYTHM 36 0.0246
141 CONTINUOUS HAEMODIAFILTRATION 24 0.0245
142 VENTRICULAR TACHYCARDIA 405 0.0245
143 ACUTE LUNG INJURY 29 0.0245
144 PRINZMETAL ANGINA 24 0.0241
145 MYOCARDIAL INJURY 27 0.0240
146 CARDIOVASCULAR INSUFFICIENCY 39 0.0239
147 GENERALISED ERYTHEMA 136 0.0239
148 PRODUCT CONTAMINATION 85 0.0239
149 PROCEDURAL COMPLICATION 183 0.0238
150 METHAEMOGLOBINAEMIA 55 0.0237
151 PUPILS UNEQUAL 27 0.0236
152 VENTRICULAR ARRHYTHMIA 86 0.0235
153 BRAIN HERNIATION 70 0.0234
154 OCULOGYRIC CRISIS 50 0.0233
155 HYPERREFLEXIA 81 0.0232
156 VENTRICULAR HYPOKINESIA 74 0.0230
157 GAZE PALSY 39 0.0229
158 BRADYCARDIA 1212 0.0228
159 BLOOD LACTIC ACID INCREASED 119 0.0226
160 PARTIAL SEIZURES 118 0.0225
161 CARDIAC ARREST 1851 0.0224
162 RHABDOMYOLYSIS 932 0.0223
163 MYOGLOBIN BLOOD INCREASED 34 0.0222
164 HEPATIC CONGESTION 21 0.0222
165 MECHANICAL VENTILATION 42 0.0221
166 ACUTE PULMONARY OEDEMA 124 0.0221
167 HYPERLACTACIDAEMIA 59 0.0220
168 AUTONOMIC NERVOUS SYSTEM IMBALANCE 64 0.0219
169 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 112 0.0218
170 SYSTOLIC DYSFUNCTION 23 0.0218
171 PO2 DECREASED 25 0.0217
172 BRAIN DEATH 67 0.0217
173 BLOOD BICARBONATE DECREASED 41 0.0216
174 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 82 0.0214
175 AMYLASE INCREASED 77 0.0208
176 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 162 0.0208
177 TOXIC ENCEPHALOPATHY 105 0.0207
178 SUPERINFECTION 31 0.0207
179 HYPORESPONSIVE TO STIMULI 24 0.0204
180 MULTI-ORGAN FAILURE 353 0.0204
181 METABOLIC ACIDOSIS 648 0.0202
182 THYROTOXIC CRISIS 23 0.0202
183 PULMONARY ALVEOLAR HAEMORRHAGE 112 0.0199
184 ATRIOVENTRICULAR BLOCK COMPLETE 133 0.0199
185 AREFLEXIA 53 0.0198
186 OLIGURIA 123 0.0198
187 NEUROMYOPATHY 21 0.0197
188 INCREASED BRONCHIAL SECRETION 50 0.0195
189 HYPOXIA 687 0.0195
190 POST PROCEDURAL COMPLICATION 373 0.0194
191 TACHYARRHYTHMIA 48 0.0192
192 PILOERECTION 21 0.0192
193 HYPERAMMONAEMIC ENCEPHALOPATHY 33 0.0190
194 LONG QT SYNDROME 45 0.0187
195 GENE MUTATION 37 0.0187
196 RESPIRATORY ALKALOSIS 30 0.0184
197 ACIDOSIS 141 0.0184
198 SHOCK 424 0.0184
199 TORTICOLLIS 39 0.0184
200 TOXIC EPIDERMAL NECROLYSIS 279 0.0184
201 HYPOVOLAEMIA 107 0.0183
202 NEUROLOGICAL DECOMPENSATION 42 0.0181
203 VENTRICULAR DYSFUNCTION 47 0.0181
204 PRIAPISM 61 0.0177
205 QUADRIPARESIS 29 0.0175
206 HYPERNATRAEMIA 87 0.0174
207 PUPIL FIXED 30 0.0173
208 LARYNGEAL OEDEMA 106 0.0172
209 OBSTRUCTIVE SLEEP APNOEA SYNDROME 25 0.0171
210 BRAIN OEDEMA 216 0.0171
211 MIXED LIVER INJURY 51 0.0169
212 SHOCK HAEMORRHAGIC 137 0.0168
213 EXTRAVASATION 69 0.0168
214 ENCEPHALITIS AUTOIMMUNE 22 0.0167
215 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 21 0.0164
216 HYPERTHERMIA 125 0.0164
217 OXYGEN SATURATION ABNORMAL 46 0.0162
218 PUPILLARY REFLEX IMPAIRED 30 0.0162
219 ISCHAEMIC HEPATITIS 22 0.0161
220 PSEUDOMONAL SEPSIS 28 0.0160
221 CONVERSION DISORDER 31 0.0160
222 ATELECTASIS 154 0.0159
223 ELECTROCARDIOGRAM T WAVE INVERSION 35 0.0158
224 TACHYPNOEA 213 0.0157
225 ACUTE RESPIRATORY DISTRESS SYNDROME 277 0.0156
226 SINUS BRADYCARDIA 151 0.0156
227 CARDIOGENIC SHOCK 223 0.0155
228 TROPONIN INCREASED 118 0.0155
229 PNEUMOMEDIASTINUM 28 0.0155
230 ATRIOVENTRICULAR BLOCK SECOND DEGREE 47 0.0155
231 SINUS TACHYCARDIA 219 0.0154
232 SUSPECTED PRODUCT QUALITY ISSUE 28 0.0153
233 SPUTUM INCREASED 33 0.0152
234 HEPATITIS FULMINANT 45 0.0152
235 INTRA-ABDOMINAL HAEMORRHAGE 36 0.0151
236 SUPRAVENTRICULAR EXTRASYSTOLES 51 0.0151
237 CHOREA 26 0.0151
238 VENTRICULAR EXTRASYSTOLES 156 0.0150
239 MULTIPLE ORGAN DYSFUNCTION SYNDROME 423 0.0149
240 HYPOTENSION 2992 0.0149
241 FOETAL DEATH 77 0.0148
242 HEPATOCELLULAR DAMAGE 33 0.0146
243 OXYGEN SATURATION DECREASED 820 0.0146
244 COAGULOPATHY 242 0.0145
245 BLOOD CREATINE PHOSPHOKINASE INCREASED 417 0.0145
246 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 138 0.0144
247 RASH MORBILLIFORM 40 0.0144
248 MUSCLE RIGIDITY 172 0.0144
249 PANCREATITIS NECROTISING 33 0.0143
250 LUNG CONSOLIDATION 40 0.0143
251 HYPERAMMONAEMIA 71 0.0142
252 PNEUMONIA STAPHYLOCOCCAL 28 0.0142
253 CHRONIC GASTRITIS 32 0.0142
254 CYTOLYTIC HEPATITIS 47 0.0141
255 LEFT VENTRICULAR DYSFUNCTION 94 0.0140
256 TACHYCARDIA 1234 0.0139
257 PARADOXICAL DRUG REACTION 51 0.0138
258 HAEMOTHORAX 40 0.0138
259 GENERALISED TONIC-CLONIC SEIZURE 228 0.0138
260 CHEST X-RAY ABNORMAL 42 0.0137
261 HEPATITIS ACUTE 89 0.0137
262 HEPARIN-INDUCED THROMBOCYTOPENIA 67 0.0136
263 DISSEMINATED INTRAVASCULAR COAGULATION 191 0.0136
264 NYSTAGMUS 72 0.0136
265 PARAPLEGIA 39 0.0135
266 BRONCHIAL DISORDER 21 0.0135
267 METABOLIC SYNDROME 22 0.0134
268 RESPIRATORY RATE DECREASED 42 0.0134
269 NEPHROGENIC ANAEMIA 61 0.0132
270 MYDRIASIS 162 0.0126
271 ATRIOVENTRICULAR BLOCK 97 0.0125
272 NEUROLEPTIC MALIGNANT SYNDROME 148 0.0125
273 FEAR OF DEATH 28 0.0124
274 HAEMODIALYSIS 104 0.0124
275 DYSTONIA 240 0.0124
276 BLOOD PRESSURE SYSTOLIC DECREASED 56 0.0123
277 RESPIRATORY ARREST 339 0.0123
278 PROCEDURAL HAEMORRHAGE 48 0.0123
279 BLOOD AMYLASE INCREASED 21 0.0123
280 UNRESPONSIVE TO STIMULI 315 0.0122
281 ABDOMINAL RIGIDITY 33 0.0122
282 COMA SCALE ABNORMAL 35 0.0121
283 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 310 0.0120
284 HYPERPARATHYROIDISM SECONDARY 30 0.0120
285 PERIORBITAL OEDEMA 62 0.0119
286 LEFT VENTRICULAR HYPERTROPHY 51 0.0119
287 SUPRAVENTRICULAR TACHYCARDIA 114 0.0119
288 DEAFNESS NEUROSENSORY 39 0.0118
289 PATENT DUCTUS ARTERIOSUS 47 0.0118
290 ACUTE HEPATIC FAILURE 160 0.0117
291 HEPATOCELLULAR INJURY 166 0.0117
292 KLEBSIELLA INFECTION 59 0.0117
293 QUADRIPLEGIA 24 0.0116
294 HYPOTHERMIA 117 0.0115
295 ANURIA 99 0.0115
296 CYANOSIS 180 0.0114
297 NECROTISING FASCIITIS 40 0.0113
298 ACCIDENTAL DEATH 21 0.0113
299 RENAL TUBULAR NECROSIS 111 0.0113
300 ATRIOVENTRICULAR BLOCK FIRST DEGREE 49 0.0113
301 HYPERKALAEMIA 395 0.0113
302 BRADYPNOEA 30 0.0111
303 CELL DEATH 22 0.0111
304 ACUTE RESPIRATORY FAILURE 212 0.0110
305 POLYURIA 90 0.0110
306 ENCEPHALOPATHY 269 0.0109
307 HEPATIC CYTOLYSIS 139 0.0109
308 HYPOVOLAEMIC SHOCK 52 0.0108
309 TONGUE OEDEMA 41 0.0107
310 POTENTIATING DRUG INTERACTION 36 0.0107
311 VASODILATATION 27 0.0107
312 ESCHERICHIA BACTERAEMIA 25 0.0106
313 BUNDLE BRANCH BLOCK LEFT 45 0.0106
314 PREMATURE DELIVERY 168 0.0105
315 BUNDLE BRANCH BLOCK RIGHT 48 0.0104
316 CARDIO-RESPIRATORY ARREST 437 0.0104
317 BRAIN INJURY 104 0.0104
318 RESPIRATORY FAILURE 752 0.0103
319 CEREBRAL ISCHAEMIA 53 0.0103
320 DISTRIBUTIVE SHOCK 23 0.0101
321 ELECTROCARDIOGRAM QT PROLONGED 365 0.0101
322 FEAR 272 0.0101
323 DRUG INTERACTION 1583 0.0100
324 COMPARTMENT SYNDROME 26 0.0100
325 STAPHYLOCOCCUS TEST POSITIVE 21 0.0100
326 STUPOR 32 0.0100
327 BILIRUBIN CONJUGATED INCREASED 23 0.0098
328 LANGUAGE DISORDER 21 0.0097
329 PREMATURE BABY 292 0.0097
330 LOW BIRTH WEIGHT BABY 77 0.0097
331 TRISMUS 50 0.0097
332 RENAL FAILURE ACUTE 410 0.0097
333 NORMAL NEWBORN 52 0.0096
334 HYPERBILIRUBINAEMIA 99 0.0095
335 INTRACRANIAL PRESSURE INCREASED 53 0.0095
336 BLOOD PRESSURE DECREASED 630 0.0095
337 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 48 0.0095
338 OBSTRUCTIVE AIRWAYS DISORDER 105 0.0094
339 DRUG LEVEL BELOW THERAPEUTIC 52 0.0094
340 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 25 0.0094
341 INCORRECT DRUG ADMINISTRATION RATE 40 0.0094
342 HEPATITIS C 113 0.0094
343 RASH MACULO-PAPULAR 208 0.0093
344 METABOLIC ENCEPHALOPATHY 28 0.0093
345 ANTINUCLEAR ANTIBODY POSITIVE 30 0.0092
346 ASPIRATION 101 0.0092
347 HEPATITIS TOXIC 24 0.0092
348 MYOCARDIAL ISCHAEMIA 104 0.0091
349 EOSINOPHILIA 160 0.0091
350 LEUKOCYTOSIS 165 0.0091
351 POST PROCEDURAL HAEMORRHAGE 106 0.0091
352 HISTIOCYTOSIS HAEMATOPHAGIC 27 0.0091
353 CLOSTRIDIUM TEST POSITIVE 20 0.0091
354 DEPRESSED LEVEL OF CONSCIOUSNESS 357 0.0090
355 SEPTIC SHOCK 390 0.0090
356 BLOOD LACTATE DEHYDROGENASE INCREASED 142 0.0090
357 PNEUMOTHORAX 141 0.0089
358 DELIRIUM 306 0.0088
359 BLOOD PHOSPHORUS INCREASED 24 0.0088
360 RESPIRATORY DISTRESS 240 0.0087
361 GRAND MAL CONVULSION 80 0.0087
362 HYPOTONIA 86 0.0086
363 METABOLIC DISORDER 50 0.0086
364 THROMBOPHLEBITIS 30 0.0085
365 WEIGHT BEARING DIFFICULTY 23 0.0085
366 DIASTOLIC DYSFUNCTION 26 0.0084
367 HYPERTONIA 48 0.0084
368 PNEUMONIA ASPIRATION 208 0.0083
369 LIP OEDEMA 35 0.0083
370 HEPATIC FAILURE 248 0.0082
371 CARDIOPULMONARY FAILURE 32 0.0082
372 HYPERTENSIVE CRISIS 91 0.0082
373 ILEUS 101 0.0081
374 RENAL INJURY 241 0.0081
375 CARDIAC FAILURE ACUTE 54 0.0081
376 CARDIAC DYSFUNCTION 30 0.0081
377 PULMONARY OEDEMA 361 0.0081
378 MOTOR DYSFUNCTION 82 0.0080
379 CHOLESTASIS 153 0.0080
380 HEPATIC NECROSIS 30 0.0080
381 FACE OEDEMA 134 0.0079
382 PERIPHERAL ISCHAEMIA 32 0.0078
383 LUNG INFILTRATION 69 0.0078
384 ENCEPHALITIS 54 0.0078
385 ELECTROCARDIOGRAM ABNORMAL 61 0.0078
386 HYPERVENTILATION 45 0.0078
387 SCOLIOSIS 48 0.0077
388 LACTIC ACIDOSIS 249 0.0077
389 URINE OUTPUT DECREASED 67 0.0077
390 CATATONIA 40 0.0076
391 ANHEDONIA 200 0.0076
392 HYPOALBUMINAEMIA 59 0.0076
393 CONJUNCTIVAL HYPERAEMIA 27 0.0076
394 AGITATION 554 0.0075
395 DRUG USE DISORDER 63 0.0075
396 PANCREATITIS ACUTE 168 0.0075
397 EXTRASYSTOLES 52 0.0074
398 CEREBRAL HAEMATOMA 25 0.0074
399 HYPERTRANSAMINASAEMIA 51 0.0073
400 BLOOD ALBUMIN DECREASED 58 0.0073
401 PARALYSIS 104 0.0073
402 RALES 42 0.0072
403 COMA 344 0.0072
404 HYPOPNOEA 25 0.0072
405 ORGAN FAILURE 29 0.0072
406 NECROSIS 40 0.0072
407 HEPATITIS 183 0.0071
408 PSEUDOMONAS INFECTION 61 0.0071
409 HYPERPYREXIA 30 0.0071
410 HYPERVOLAEMIA 35 0.0071
411 DISEASE COMPLICATION 32 0.0070
412 EMBOLIC STROKE 24 0.0068
413 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 372 0.0068
414 ACUTE KIDNEY INJURY 1024 0.0067
415 HEPATITIS CHOLESTATIC 40 0.0066
416 ALTERED STATE OF CONSCIOUSNESS 143 0.0066
417 EYE MOVEMENT DISORDER 45 0.0066
418 STEVENS-JOHNSON SYNDROME 146 0.0066
419 BLOOD CALCIUM DECREASED 73 0.0065
420 LEUKOENCEPHALOPATHY 24 0.0064
421 COVID-19 PNEUMONIA 76 0.0064
422 BLOOD POTASSIUM INCREASED 104 0.0064
423 DUODENAL ULCER 45 0.0064
424 THROMBOTIC MICROANGIOPATHY 62 0.0064
425 DERMATITIS BULLOUS 46 0.0063
426 ANGIOEDEMA 276 0.0062
427 MONOPLEGIA 27 0.0062
428 DYSKINESIA 252 0.0062
429 SALIVARY HYPERSECRETION 62 0.0062
430 FIBRIN D DIMER INCREASED 22 0.0062
431 PROTHROMBIN TIME PROLONGED 37 0.0062
432 CARDIOMEGALY 76 0.0062
433 RENAL IMPAIRMENT 519 0.0062
434 RENAL FAILURE 820 0.0062
435 ALANINE AMINOTRANSFERASE INCREASED 376 0.0061
436 ANGIOPATHY 34 0.0061
437 TOXIC SKIN ERUPTION 61 0.0061
438 INJURY 424 0.0060
439 HYPERLIPIDAEMIA 72 0.0060
440 IRON DEFICIENCY 27 0.0060
441 MUSCLE CONTRACTIONS INVOLUNTARY 21 0.0060
442 TRICUSPID VALVE INCOMPETENCE 47 0.0059
443 SUBARACHNOID HAEMORRHAGE 60 0.0059
444 CARDIOTOXICITY 52 0.0058
445 HYPOPHOSPHATAEMIA 43 0.0058
446 BLOOD MAGNESIUM DECREASED 50 0.0058
447 FOETAL EXPOSURE DURING PREGNANCY 470 0.0058
448 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 35 0.0057
449 PULMONARY HAEMORRHAGE 45 0.0057
450 CREATININE RENAL CLEARANCE DECREASED 23 0.0057
451 BLOOD BILIRUBIN INCREASED 154 0.0057
452 SPINAL OSTEOARTHRITIS 50 0.0057
453 BREATH SOUNDS ABNORMAL 28 0.0057
454 MITRAL VALVE INCOMPETENCE 64 0.0056
455 INFUSION SITE EXTRAVASATION 35 0.0056
456 FOETAL GROWTH RESTRICTION 34 0.0056
457 ARTERIOSCLEROSIS CORONARY ARTERY 37 0.0056
458 NO THERAPEUTIC RESPONSE 68 0.0056
459 TRANSAMINASES INCREASED 124 0.0056
460 MALABSORPTION 29 0.0055
461 BLOOD TRIGLYCERIDES INCREASED 98 0.0055
462 NEUROTOXICITY 97 0.0055
463 AMMONIA INCREASED 28 0.0055
464 CARDIAC TAMPONADE 26 0.0055
465 ASPARTATE AMINOTRANSFERASE INCREASED 290 0.0055
466 MATERNAL EXPOSURE DURING PREGNANCY 483 0.0054
467 GUILLAIN-BARRE SYNDROME 26 0.0054
468 DEMYELINATION 22 0.0054
469 PERFORMANCE STATUS DECREASED 25 0.0054
470 DRUG TOXICITY 72 0.0053
471 CEREBRAL ATROPHY 21 0.0053
472 AZOTAEMIA 21 0.0053
473 MENTAL STATUS CHANGES 145 0.0052
474 CARDIOMYOPATHY 77 0.0052
475 EXPOSURE DURING PREGNANCY 323 0.0052
476 BODY TEMPERATURE INCREASED 106 0.0052
477 ARRHYTHMIA 246 0.0052
478 WRONG PRODUCT ADMINISTERED 35 0.0052
479 AORTIC VALVE INCOMPETENCE 22 0.0052
480 ILEUS PARALYTIC 23 0.0051
481 HYDROCEPHALUS 28 0.0051
482 CHROMATURIA 116 0.0051
483 BACTERAEMIA 60 0.0051
484 COLITIS ISCHAEMIC 34 0.0050
485 SCREAMING 32 0.0050
486 PNEUMONIA BACTERIAL 46 0.0050
487 ISCHAEMIA 23 0.0050
488 CAESAREAN SECTION 58 0.0050
489 ATAXIA 59 0.0050
490 ENTEROCOCCAL INFECTION 24 0.0050
491 DIALYSIS 70 0.0049
492 ABSCESS LIMB 21 0.0049
493 HEART RATE DECREASED 172 0.0049
494 EJECTION FRACTION DECREASED 76 0.0049
495 HYPOMAGNESAEMIA 68 0.0049
496 SEPSIS 539 0.0048
497 HYPOKALAEMIA 223 0.0048
498 CLOSTRIDIUM DIFFICILE COLITIS 51 0.0048
499 DIVERTICULUM INTESTINAL 21 0.0048
500 PREMATURE LABOUR 27 0.0048
501 DRUG LEVEL INCREASED 79 0.0048
502 ATRIAL FLUTTER 38 0.0048
503 PHYSICAL DISABILITY 21 0.0047
504 MIOSIS 38 0.0047
505 HEPATIC ENCEPHALOPATHY 44 0.0047
506 LIPASE INCREASED 36 0.0047
507 TOXICITY TO VARIOUS AGENTS 786 0.0047
508 DRUG-INDUCED LIVER INJURY 146 0.0046
509 LIVER INJURY 114 0.0046
510 PULMONARY CONGESTION 61 0.0046
511 RESPIRATORY DISORDER 137 0.0046
512 CONCOMITANT DISEASE AGGRAVATED 28 0.0045
513 EPILEPSY 138 0.0045
514 JAUNDICE 121 0.0045
515 POOR QUALITY DRUG ADMINISTERED 29 0.0045
516 HEPATOMEGALY 44 0.0045
517 ELECTROLYTE IMBALANCE 52 0.0045
518 ATRIAL FIBRILLATION 435 0.0045
519 STAPHYLOCOCCAL SEPSIS 22 0.0045
520 SEDATION 116 0.0044
521 HAEMOLYSIS 34 0.0044
522 HEPATIC FUNCTION ABNORMAL 164 0.0044
523 EYELID OEDEMA 51 0.0044
524 INTESTINAL PERFORATION 49 0.0044
525 ACUTE CORONARY SYNDROME 36 0.0043
526 AGRANULOCYTOSIS 80 0.0043
527 HAEMATEMESIS 109 0.0043
528 ENDOCARDITIS 22 0.0043
529 POLYP 28 0.0043
530 MYOCARDITIS 49 0.0043
531 ANAL ABSCESS 23 0.0043
532 HEPATOTOXICITY 95 0.0043
533 PERIORBITAL SWELLING 24 0.0042
534 UNEVALUABLE EVENT 320 0.0042
535 CARDIOVASCULAR DISORDER 106 0.0042
536 SERUM FERRITIN INCREASED 22 0.0042
537 ABORTION INDUCED 39 0.0041
538 RIGHT VENTRICULAR FAILURE 29 0.0041
539 MUSCLE TWITCHING 95 0.0041
540 RASH PUSTULAR 30 0.0041
541 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 42 0.0041
542 EMPHYSEMA 41 0.0041
543 THROMBOCYTOPENIA 453 0.0040
544 ASCITES 119 0.0040
545 SEIZURE 465 0.0040
546 INCOHERENT 26 0.0040
547 DERMATITIS EXFOLIATIVE 20 0.0040
548 CONVULSION 228 0.0040
549 ENTEROCOLITIS 23 0.0040
550 RESPIRATORY RATE INCREASED 35 0.0039
551 PULMONARY HYPERTENSION 82 0.0039
552 DRUG RESISTANCE 101 0.0039
553 BLOOD CREATININE INCREASED 256 0.0039
554 RESPIRATION ABNORMAL 27 0.0039
555 FLUID OVERLOAD 57 0.0039
556 BLOOD ALKALINE PHOSPHATASE INCREASED 97 0.0039
557 RENAL FAILURE CHRONIC 30 0.0039
558 BLOOD UREA INCREASED 65 0.0039
559 POST-TRAUMATIC STRESS DISORDER 26 0.0039
560 GENERALISED OEDEMA 48 0.0039
561 MEDICATION ERROR 215 0.0039
562 ERYTHEMA MULTIFORME 36 0.0039
563 HEMIPLEGIA 32 0.0038
564 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 34 0.0038
565 MALNUTRITION 43 0.0038
566 END STAGE RENAL DISEASE 70 0.0038
567 ACUTE MYOCARDIAL INFARCTION 113 0.0038
568 MYOPATHY 33 0.0038
569 REBOUND EFFECT 43 0.0038
570 HAEMOLYTIC ANAEMIA 34 0.0038
571 HAEMOPTYSIS 105 0.0038
572 PLEURAL EFFUSION 229 0.0038
573 DISORIENTATION 149 0.0038
574 BRONCHOPULMONARY ASPERGILLOSIS 29 0.0037
575 CHOLECYSTITIS ACUTE 21 0.0037
576 DECUBITUS ULCER 30 0.0037
577 DERMATITIS ALLERGIC 46 0.0037
578 HYPERAESTHESIA 30 0.0036
579 ULCER 58 0.0036
580 CEREBRAL INFARCTION 89 0.0036
581 HYPERCHOLESTEROLAEMIA 35 0.0036
582 GAMMA-GLUTAMYLTRANSFERASE INCREASED 80 0.0036
583 PALLOR 98 0.0036
584 LIVER FUNCTION TEST INCREASED 77 0.0036
585 CEREBRAL HAEMORRHAGE 128 0.0036
586 CHILLS 418 0.0036
587 OROPHARYNGEAL DISCOMFORT 32 0.0035
588 ESCHERICHIA INFECTION 29 0.0035
589 DIVERTICULUM 25 0.0035
590 ARTERIOSCLEROSIS 33 0.0035
591 INTERVERTEBRAL DISC DEGENERATION 32 0.0035
592 LARGE INTESTINE PERFORATION 24 0.0035
593 DRUG ERUPTION 61 0.0034
594 PSYCHOMOTOR HYPERACTIVITY 57 0.0034
595 LIVER FUNCTION TEST ABNORMAL 99 0.0034
596 HYPERGLYCAEMIA 124 0.0034
597 HAEMATURIA 116 0.0034
598 TUBULOINTERSTITIAL NEPHRITIS 63 0.0034
599 LIVE BIRTH 28 0.0033
600 ANAL INCONTINENCE 30 0.0033
601 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 25 0.0033
602 HYPOCALCAEMIA 63 0.0033
603 APHASIA 100 0.0033
604 RENAL CYST 26 0.0033
605 EXTRAPYRAMIDAL DISORDER 81 0.0033
606 SENSORY LOSS 26 0.0032
607 PANCREATITIS 170 0.0032
608 TUMOUR LYSIS SYNDROME 28 0.0032
609 HEPATIC STEATOSIS 59 0.0032
610 THERAPY NON-RESPONDER 142 0.0032
611 RESTLESSNESS 115 0.0031
612 RASH ERYTHEMATOUS 150 0.0031
613 ADRENAL INSUFFICIENCY 38 0.0031
614 QUALITY OF LIFE DECREASED 42 0.0031
615 POISONING 39 0.0031
616 RASH GENERALISED 80 0.0031
617 HIATUS HERNIA 40 0.0031
618 SWOLLEN TONGUE 96 0.0031
619 HEMIPARESIS 52 0.0031
620 POISONING DELIBERATE 29 0.0031
621 CYTOKINE RELEASE SYNDROME 61 0.0030
622 LYMPHOPENIA 43 0.0030
623 CARDIAC FAILURE 243 0.0030
624 CHOLECYSTITIS CHRONIC 20 0.0030
625 BLINDNESS TRANSIENT 22 0.0030
626 URTICARIA 497 0.0030
627 PYREXIA 1024 0.0030
628 NERVOUS SYSTEM DISORDER 92 0.0029
629 MUSCLE SPASTICITY 36 0.0029
630 HICCUPS 24 0.0029
631 POLYNEUROPATHY 35 0.0029
632 WRONG DRUG ADMINISTERED 26 0.0029
633 DYSARTHRIA 108 0.0029
634 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 49 0.0029
635 BLOOD PRESSURE DIASTOLIC DECREASED 21 0.0028
636 ERYTHEMA 584 0.0028
637 INCONTINENCE 30 0.0028
638 COGNITIVE DISORDER 132 0.0028
639 HAEMATOMA 73 0.0028
640 NEPHROPATHY TOXIC 31 0.0028
641 ABSCESS 44 0.0028
642 LOSS OF CONSCIOUSNESS 350 0.0027
643 ACCIDENTAL OVERDOSE 99 0.0027
644 HEART RATE INCREASED 268 0.0027
645 EMOTIONAL DISTRESS 327 0.0027
646 HYPERTENSION 570 0.0027
647 NEPHROPATHY 25 0.0027
648 UPPER GASTROINTESTINAL HAEMORRHAGE 45 0.0027
649 HYPERCALCAEMIA 33 0.0027
650 PROCEDURAL PAIN 74 0.0027
651 SKIN LACERATION 29 0.0027
652 WHITE BLOOD CELL COUNT INCREASED 102 0.0027
653 HAEMATOCRIT DECREASED 52 0.0026
654 BLOOD DISORDER 21 0.0026
655 HYPOKINESIA 38 0.0026
656 WHEEZING 155 0.0026
657 THERAPEUTIC PRODUCT EFFECT DECREASED 117 0.0026
658 NERVE INJURY 29 0.0026
659 MUSCLE ATROPHY 33 0.0026
660 UROSEPSIS 24 0.0026
661 URINARY INCONTINENCE 77 0.0026
662 AGGRESSION 130 0.0026
663 SUBSTANCE ABUSE 21 0.0026
664 URINARY RETENTION 86 0.0026
665 CONTRAINDICATED PRODUCT ADMINISTERED 78 0.0026
666 INTENTIONAL OVERDOSE 165 0.0026
667 HEPATIC CIRRHOSIS 48 0.0026
668 HAEMORRHAGE INTRACRANIAL 38 0.0025
669 INTERNATIONAL NORMALISED RATIO INCREASED 72 0.0025
670 STAPHYLOCOCCAL INFECTION 83 0.0025
671 HAEMORRHOIDS 49 0.0025
672 DRUG EFFECT DECREASED 135 0.0025
673 AKATHISIA 34 0.0025
674 COMPLETED SUICIDE 207 0.0025
675 SECRETION DISCHARGE 31 0.0025
676 WOUND INFECTION 27 0.0025
677 DEEP VEIN THROMBOSIS 160 0.0025
678 BLOOD PRESSURE SYSTOLIC INCREASED 48 0.0025
679 MOVEMENT DISORDER 79 0.0025
680 GLOMERULAR FILTRATION RATE DECREASED 30 0.0024
681 PRODUCT USE IN UNAPPROVED INDICATION 605 0.0024
682 OVERDOSE 525 0.0024
683 C-REACTIVE PROTEIN INCREASED 88 0.0024
684 LIVER DISORDER 107 0.0024
685 PULMONARY EMBOLISM 228 0.0024
686 PETECHIAE 25 0.0024
687 LIP SWELLING 79 0.0024
688 PARKINSONISM 23 0.0024
689 SLEEP APNOEA SYNDROME 45 0.0024
690 GASTROINTESTINAL HAEMORRHAGE 196 0.0023
691 SUICIDE ATTEMPT 142 0.0023
692 OEDEMA 127 0.0023
693 ADVERSE REACTION 31 0.0023
694 CHOLECYSTITIS 27 0.0023
695 CONFUSIONAL STATE 366 0.0023
696 NEUTROPHIL COUNT INCREASED 23 0.0022
697 CORONARY ARTERY DISEASE 68 0.0022
698 HAEMORRHAGE 234 0.0022
699 SUBDURAL HAEMATOMA 32 0.0022
700 DRUG ABUSE 184 0.0022
701 HYPONATRAEMIA 124 0.0022
702 SOPOR 29 0.0022
703 DRUG INEFFECTIVE 2858 0.0022
704 PERICARDIAL EFFUSION 50 0.0022
705 DRUG LEVEL DECREASED 22 0.0022
706 SPLENOMEGALY 25 0.0021
707 ISCHAEMIC STROKE 38 0.0021
708 TRANSFUSION 22 0.0021
709 CONDITION AGGRAVATED 633 0.0021
710 JOINT DISLOCATION 22 0.0021
711 SOMNOLENCE 419 0.0021
712 DIPLOPIA 54 0.0021
713 PANCYTOPENIA 116 0.0021
714 PSYCHOTIC DISORDER 61 0.0021
715 CHRONIC KIDNEY DISEASE 155 0.0020
716 LEUKOPENIA 101 0.0020
717 CYST 25 0.0020
718 WITHDRAWAL SYNDROME 84 0.0020
719 GASTRIC ULCER 38 0.0020
720 OFF LABEL USE 1736 0.0020
721 DYSPHAGIA 187 0.0020
722 OSTEOARTHRITIS 83 0.0020
723 SPEECH DISORDER 102 0.0019
724 MENTAL IMPAIRMENT 47 0.0019
725 BLOOD PRESSURE FLUCTUATION 46 0.0019
726 GENERAL PHYSICAL HEALTH DETERIORATION 221 0.0019
727 MELAENA 42 0.0019
728 CHOLELITHIASIS 62 0.0019
729 DEVICE RELATED INFECTION 29 0.0019
730 DISABILITY 37 0.0019
731 HYPERHIDROSIS 241 0.0019
732 HYPERSENSITIVITY 346 0.0019
733 BLOOD POTASSIUM DECREASED 56 0.0019
734 ANXIETY 530 0.0019
735 HAEMOGLOBIN DECREASED 190 0.0018
736 PLATELET COUNT INCREASED 24 0.0018
737 PHARYNGEAL OEDEMA 28 0.0018
738 INTERSTITIAL LUNG DISEASE 88 0.0018
739 MUSCULAR WEAKNESS 206 0.0018
740 HYPERTHYROIDISM 26 0.0018
741 SPINAL PAIN 21 0.0018
742 PNEUMONIA 580 0.0018
743 ECONOMIC PROBLEM 27 0.0018
744 ANAEMIA 339 0.0018
745 SKIN REACTION 25 0.0018
746 HYPOGLYCAEMIA 86 0.0018
747 MANIA 29 0.0018
748 TREATMENT FAILURE 146 0.0018
749 IMPAIRED GASTRIC EMPTYING 24 0.0018
750 HEPATIC ENZYME INCREASED 120 0.0018
751 PROTEINURIA 33 0.0017
752 RETCHING 37 0.0017
753 WRONG TECHNIQUE IN DRUG USAGE PROCESS 63 0.0017
754 DRUG ADMINISTRATION ERROR 53 0.0017
755 SMALL INTESTINAL OBSTRUCTION 21 0.0017
756 HALLUCINATION, VISUAL 36 0.0017
757 LYMPHOCYTE COUNT DECREASED 30 0.0017
758 PERITONITIS 35 0.0017
759 SENSORY DISTURBANCE 27 0.0017
760 ABDOMINAL DISTENSION 175 0.0017
761 DRUG EXPOSURE DURING PREGNANCY 57 0.0017
762 GASTRITIS 44 0.0017
763 BACTERIAL INFECTION 31 0.0017
764 BLOOD PRESSURE INCREASED 254 0.0017
765 RASH 722 0.0017
766 DRUG WITHDRAWAL SYNDROME 145 0.0017
767 HYPOTHYROIDISM 52 0.0016
768 DIVERTICULITIS 45 0.0016
769 FLUSHING 163 0.0016
770 PRODUCT ADMINISTRATION ERROR 32 0.0016
771 FEBRILE NEUTROPENIA 105 0.0016
772 PNEUMONITIS 43 0.0016
773 RASH MACULAR 55 0.0016
774 RASH PAPULAR 35 0.0016
775 DRUG EFFECT LESS THAN EXPECTED 23 0.0016
776 SWELLING FACE 101 0.0015
777 PRESCRIBED OVERDOSE 30 0.0015
778 CELLULITIS 78 0.0015
779 RESTLESS LEGS SYNDROME 28 0.0015
780 SNEEZING 34 0.0015
781 PLATELET COUNT DECREASED 161 0.0015
782 AMNESIA 98 0.0015
783 COORDINATION ABNORMAL 21 0.0015
784 VOMITING 704 0.0015
785 MUSCLE TIGHTNESS 24 0.0015
786 INFLAMMATION 76 0.0015
787 CLOSTRIDIUM DIFFICILE INFECTION 32 0.0015
788 SCAR 25 0.0015
789 OSTEOPENIA 22 0.0014
790 LUNG DISORDER 71 0.0014
791 TREMOR 238 0.0014
792 TREATMENT NONCOMPLIANCE 77 0.0014
793 IMPAIRED WORK ABILITY 30 0.0014
794 LETHARGY 80 0.0014
795 CONJUNCTIVITIS 25 0.0013
796 COLITIS 51 0.0013
797 HALLUCINATION 101 0.0013
798 EPISTAXIS 100 0.0013
799 DYSURIA 49 0.0013
800 CARDIAC FAILURE CONGESTIVE 104 0.0013
801 BLISTER 72 0.0013
802 GASTROOESOPHAGEAL REFLUX DISEASE 103 0.0013
803 METASTASES TO BONE 21 0.0013
804 BONE MARROW FAILURE 26 0.0013
805 OSTEOMYELITIS 23 0.0013
806 INCORRECT ROUTE OF DRUG ADMINISTRATION 45 0.0013
807 MOOD SWINGS 40 0.0013
808 COLD SWEAT 22 0.0012
809 DYSPNOEA EXERTIONAL 47 0.0012
810 CANDIDA INFECTION 21 0.0012
811 OEDEMA PERIPHERAL 151 0.0012
812 ABNORMAL BEHAVIOUR 49 0.0012
813 INTENTIONAL PRODUCT MISUSE 108 0.0012
814 DYSPNOEA 697 0.0012
815 FUNGAL INFECTION 41 0.0012
816 PHOTOPHOBIA 23 0.0012
817 MENTAL DISORDER 53 0.0012
818 PAIN 747 0.0012
819 OSTEONECROSIS OF JAW 30 0.0012
820 BLOOD PRESSURE ABNORMAL 24 0.0012
821 LIMB DISCOMFORT 37 0.0012
822 HEART RATE IRREGULAR 27 0.0012
823 PHARMACEUTICAL PRODUCT COMPLAINT 31 0.0012
824 RECTAL HAEMORRHAGE 51 0.0012
825 LYMPHADENOPATHY 42 0.0012
826 NEUTROPENIA 161 0.0012
827 COUGH 327 0.0012
828 THERAPEUTIC RESPONSE DECREASED 70 0.0012
829 DEAFNESS 30 0.0011
830 SYNCOPE 114 0.0011
831 INFECTION 164 0.0011
832 TINNITUS 52 0.0011
833 DEHYDRATION 150 0.0011
834 PRODUCT QUALITY ISSUE 152 0.0011
835 ABDOMINAL PAIN 260 0.0011
836 BONE DISORDER 20 0.0011
837 FLATULENCE 62 0.0011
838 MYALGIA 185 0.0011
839 MYOCARDIAL INFARCTION 189 0.0011
840 SKIN ULCER 28 0.0011
841 FAECES DISCOLOURED 23 0.0011
842 PAIN IN JAW 30 0.0011
843 RED BLOOD CELL COUNT DECREASED 30 0.0010
844 TRANSIENT ISCHAEMIC ATTACK 35 0.0010
845 CEREBROVASCULAR ACCIDENT 173 0.0010
846 BACK PAIN 237 0.0010
847 DEPRESSION 232 0.0010
848 INTENTIONAL PRODUCT USE ISSUE 89 0.0010
849 CHEST PAIN 188 0.0010
850 RENAL DISORDER 47 0.0010
851 FEELING COLD 28 0.0010
852 OROPHARYNGEAL PAIN 93 0.0010
853 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 71 0.0010
854 CARDIAC DISORDER 93 0.0010
855 ASTHENIA 366 0.0010
856 URINARY TRACT INFECTION 164 0.0010
857 DIABETIC KETOACIDOSIS 23 0.0010
858 SKIN LESION 26 0.0009
859 PRESYNCOPE 23 0.0009
860 DISTURBANCE IN ATTENTION 51 0.0009
861 NEUTROPHIL COUNT DECREASED 38 0.0009
862 THROMBOSIS 75 0.0009
863 WOUND 26 0.0009
864 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 27 0.0009
865 PRODUCTIVE COUGH 44 0.0009
866 SLEEP DISORDER 65 0.0009
867 RASH PRURITIC 49 0.0009
868 DISEASE RECURRENCE 43 0.0009
869 NAUSEA 713 0.0009
870 IRRITABILITY 54 0.0009
871 CHEST DISCOMFORT 91 0.0009
872 DRUG EFFECT INCOMPLETE 32 0.0009
873 DIABETES MELLITUS 67 0.0009
874 PRODUCT USE ISSUE 165 0.0009
875 PARAESTHESIA 138 0.0009
876 EMOTIONAL DISORDER 27 0.0009
877 IMPAIRED HEALING 28 0.0009
878 TARDIVE DYSKINESIA 24 0.0008
879 PANIC ATTACK 31 0.0008
880 SKIN DISCOLOURATION 39 0.0008
881 FEELING HOT 52 0.0008
882 RESPIRATORY TRACT INFECTION 22 0.0008
883 ANGINA PECTORIS 24 0.0008
884 HYPOAESTHESIA 124 0.0008
885 DISCOMFORT 49 0.0008
886 NO ADVERSE EVENT 144 0.0008
887 DYSPHONIA 46 0.0008
888 MEMORY IMPAIRMENT 108 0.0008
889 MUSCULOSKELETAL STIFFNESS 68 0.0008
890 SWELLING 72 0.0008
891 POLLAKIURIA 32 0.0008
892 MOBILITY DECREASED 53 0.0007
893 UPPER RESPIRATORY TRACT INFECTION 34 0.0007
894 NECK PAIN 41 0.0007
895 RHINORRHOEA 47 0.0007
896 INFUSION RELATED REACTION 48 0.0007
897 GAIT DISTURBANCE 138 0.0007
898 SKIN DISORDER 24 0.0007
899 MUSCLE SPASMS 132 0.0007
900 BLINDNESS 29 0.0007
901 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 37 0.0007
902 ASTHMA 79 0.0007
903 HEAD INJURY 22 0.0007
904 PRODUCT SUBSTITUTION ISSUE 40 0.0007
905 CONSTIPATION 151 0.0007
906 HAEMATOCHEZIA 38 0.0007
907 INFLUENZA LIKE ILLNESS 56 0.0007
908 NEPHROLITHIASIS 31 0.0007
909 VAGINAL HAEMORRHAGE 29 0.0007
910 MUSCULOSKELETAL PAIN 35 0.0007
911 CYSTITIS 21 0.0007
912 PALPITATIONS 76 0.0006
913 WHITE BLOOD CELL COUNT DECREASED 70 0.0006
914 PRURITUS 245 0.0006
915 NERVOUSNESS 33 0.0006
916 WEIGHT DECREASED 176 0.0006
917 VISION BLURRED 85 0.0006
918 LOWER RESPIRATORY TRACT INFECTION 28 0.0006
919 DEATH 530 0.0006
920 INTESTINAL OBSTRUCTION 23 0.0006
921 ILL-DEFINED DISORDER 37 0.0006
922 MIGRAINE 58 0.0006
923 DISEASE PROGRESSION 70 0.0006
924 DRUG DEPENDENCE 95 0.0006
925 ABDOMINAL PAIN UPPER 121 0.0006
926 BURNING SENSATION 41 0.0006
927 VISUAL IMPAIRMENT 72 0.0006
928 BRONCHITIS 43 0.0006
929 BALANCE DISORDER 50 0.0006
930 CATARACT 34 0.0006
931 EXTRA DOSE ADMINISTERED 23 0.0006
932 DIZZINESS 283 0.0006
933 INSOMNIA 151 0.0006
934 OSTEOPOROSIS 23 0.0006
935 FLUID RETENTION 28 0.0005
936 HEADACHE 345 0.0005
937 GASTROINTESTINAL DISORDER 49 0.0005
938 NEUROPATHY PERIPHERAL 52 0.0005
939 SURGERY 32 0.0005
940 ARTHROPATHY 30 0.0005
941 THROAT IRRITATION 24 0.0005
942 ROAD TRAFFIC ACCIDENT 22 0.0005
943 DIARRHOEA 339 0.0005
944 VERTIGO 32 0.0005
945 DYSPEPSIA 51 0.0005
946 COVID-19 90 0.0005
947 HYPOACUSIS 22 0.0005
948 DECREASED APPETITE 118 0.0005
949 PAIN IN EXTREMITY 149 0.0005
950 FALL 168 0.0005
951 ECZEMA 26 0.0005
952 MALAISE 214 0.0005
953 DEVICE DISLOCATION 21 0.0005
954 DRUG INTOLERANCE 46 0.0005
955 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
956 ADVERSE DRUG REACTION 41 0.0005
957 STOMATITIS 27 0.0004
958 THERAPY CESSATION 22 0.0004
959 CONTUSION 41 0.0004
960 BLOOD GLUCOSE INCREASED 80 0.0004
961 DEVICE ISSUE 38 0.0004
962 INCORRECT DOSE ADMINISTERED 94 0.0004
963 SUICIDAL IDEATION 37 0.0004
964 DYSGEUSIA 30 0.0004
965 SKIN EXFOLIATION 34 0.0004
966 HERPES ZOSTER 23 0.0004
967 INJECTION SITE SWELLING 30 0.0004
968 DRY MOUTH 31 0.0004
969 EYE PAIN 21 0.0004
970 INFLUENZA 41 0.0004
971 PERIPHERAL SWELLING 55 0.0004
972 FATIGUE 276 0.0004
973 RHEUMATOID ARTHRITIS 39 0.0003
974 ADVERSE EVENT 31 0.0003
975 INJECTION SITE REACTION 23 0.0003
976 SINUSITIS 34 0.0003
977 WEIGHT INCREASED 74 0.0003
978 ARTHRALGIA 136 0.0003
979 FEELING ABNORMAL 78 0.0003
980 ABDOMINAL DISCOMFORT 53 0.0003
981 UNDERDOSE 23 0.0003
982 DEVICE MALFUNCTION 22 0.0003
983 MALIGNANT NEOPLASM PROGRESSION 29 0.0003
984 ARTHRITIS 21 0.0003
985 ACCIDENTAL EXPOSURE TO PRODUCT 27 0.0003
986 JOINT SWELLING 26 0.0002
987 NASOPHARYNGITIS 36 0.0002
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 38 0.0002
989 ALOPECIA 35 0.0002
990 INJECTION SITE ERYTHEMA 21 0.0002
991 PRODUCT DOSE OMISSION ISSUE 48 0.0002
992 HOSPITALISATION 25 0.0002
993 INJECTION SITE PAIN 44 0.0001
994 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 25 0.0001